Editorial
Journal of Generic Medicines (2007) 5, 1–3. doi:10.1057/palgrave.jgm.4950094
Creating a workable biogenerics pathway for patients
Kathleen Jaeger1
1President and CEO, Generic Pharmaceutical Association (GPhA), 2300 Clarendon Boulevard, Suite 400, Washington, DC 22201, USA Tel: +1 703 647 2480; E-mail: KJaeger@gphaonline.org
